What is Pulsenmore?
Pulsenmore has pioneered the development of the first universally accessible home ultrasound device designed for remote and reliable patient care. Their innovative technology allows patients to perform self-scans using a smartphone connected to a handheld ultrasound cradle. The captured scans are then automatically transmitted for remote clinical assessment by healthcare professionals. This at-home prenatal ultrasound system for remote fetal wellbeing assessment empowers women to actively manage their pregnancies in collaboration with their medical providers, aiming to improve care accessibility, optimize resource allocation, and enhance overall patient satisfaction.
How much funding has Pulsenmore raised?
Pulsenmore has raised a total of $50M across 1 funding round:
Corporate Investment
$50M
Corporate Investment (2022): $50M with participation from GE Healthcare
Key Investors in Pulsenmore
GE Healthcare
GE HealthCare is a global medical technology and healthcare solutions organization known for its innovation in the health care industry. They develop and deliver a broad portfolio of advanced products including imaging systems, patient monitoring tools, and ultrasound equipment, aiming to improve productivity, expand access, and enhance outcomes in clinical environments.
What's next for Pulsenmore?
With a recent major strategic investment, Pulsenmore is poised for significant expansion. The company's focus on enhancing remote care accessibility through its unique home ultrasound technology positions it for substantial growth in the evolving healthcare landscape. Future developments are likely to involve scaling production, broadening clinical applications beyond prenatal care, and further integrating their platform with healthcare provider networks to streamline remote diagnostic workflows and improve patient outcomes.
See full Pulsenmore company page
